Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma

Published:2020-08 Issue: Volume:21 Page:e00171
ISSN:2352-5517
Container-title:Practical Laboratory Medicine
language:en
Short-container-title:Practical Laboratory Medicine

Author:

Hartley Christopher,Rowan Daniel,Chen Xiuxu,Gomez-Arellano Luisa,West Anna Marie,Oshima Kiyoko,Mackinnon Alexander Craig

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Radiological and Ultrasound Technology

Reference33 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2013

2. State of the art and future directions of pancreatic ductal adenocarcinoma therapy;Neuzillet;Pharmacol. Therapeut.,2015

3. A phase II clinical trial of molecular profiled Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma;Tsai;Ann. Surg.,2018

4. Human correlates of provocative questions in pancreatic pathology;McDonald;Adv. Anat. Pathol.,2012

5. Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer? Cellular and molecular life sciences;Liang;CMLS,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety;Biomedicines;2023-07-15

2. Generation of β-like cell subtypes from differentiated human induced pluripotent stem cells in 3D spheroids;Molecular Omics;2023

3. Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer;Frontiers in Immunology;2022-09-26

4. SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC;International Journal of Biological Sciences;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3